Submitted by: Submitted by Marketreport
Views: 10
Words: 1157
Pages: 5
Category: Business and Industry
Date Submitted: 07/07/2016 09:52 PM
Summary
Technavio Announces the Publication of its Research Report Global Human Albumin Market 2016-2020
Technavio recognizes the following companies as the key players in the global human albumin market: CSL Behring, Grifols, Baxalta, Octapharma, and Kedrion.
Other Prominent Vendors in the market are: AADi, Ablynx, Albumedix, Ampio Pharmaceuticals, Azaya Therapeutics, Beijing Tiantan, Biotest, Bristol-Myers Squibb, Celgene, ConjuChem, GSK, Hebei Changshan Biochem Pharma, HiMedia Laboratories, Hualan Biological Engineering, InVittria, MedxBio, Merck, Mitsubishi Tanabe Pharma, NantBioScience, Novo Nordisk, Novozymes, Shanghai RAAS Blood Products, Sucampo Pharmaceuticals, Teva Pharmaceuticals, Thermo Fisher Scientific, Tianjin SinoBiotech & Beijing Bio-Fortune, Ventria Bioscience, and Yoshitomi Pharmaceutical.
Browse Detail Report With TOC @
https://marketreportscenter.com/reports/316888/global-human-albumin-market-2016-2020
Commenting on the report, an analyst from Technavios team said: A trend helping to propel market growth is the rise in non-therapeutic applications. Non-therapeutic applications of albumin are on a rise. Research is yet to evaluate the applications of albumin as an excipient for commercial use. Some areas where albumin can be employed are as a drug-formulating agent, an ingredient in vaccines and sealant in surgeries, and to coat medical devices and equipment. Though the current supply of albumin for non-therapeutic purposes is low, the high interest shown by the research institutes and pharmaceutical and biopharmaceutical companies in investigating the potential non-therapeutic uses of albumin is expected to drive the market.
According to the report, a key driver is the high demand for human albumin in China. China is the largest market for albumin products. Albumin is being used as a volume replacement therapy and for treating kidney diseases, cirrhosis, and cancer. But the demand for plasma products, primarily albumin...